Skip to main content
Download PDF

Effusion detected by ultrasonography and overweight may predict the risk of knee osteoarthritis in females with early knee osteoarthritis: a retrospective analysis of Iwaki cohort data

BMC Musculoskeletal Disorders volume 23, Article number: 1021 (2022) Cite this article

Abstract

Background

Knee osteoarthritis (OA) has enormous medical and socioeconomic burdens, which early diagnosis and intervention can reduce. We investigated the influence of knee effusion on the progression of knee OA in patients with early knee OA.

Methods

A total of 404 participants without radiographic knee OA were assessed from a 3-year longitudinal analysis. Participants were classified into non-OA and early knee OA groups. The effusion area (mm2) was quantified using ultrasonography. Receiver operating characteristic and logistic regression analyses were performed.

Results

At the 3-year follow-up, 114 of 349 knees (32%) had progressed from non-OA and 32 of 55 knees (58%) had progressed from early knee OA to radiographic knee OA. Logistic regression analysis showed that female sex (odds ratio [OR] 3.36, 95% confidence interval [CIs] 2.98–5.42), early knee OA (OR 2.02, 95% CI 1.08–3.75), body mass index (OR 1.11, 95% CI 1.02–1.19), and effusion area (OR 1.01, 95% CI 1.01–1.02) were significantly correlated with knee OA progression. Women who were overweight (body mass index ≥ 25 kg/m2) with more severe effusion had a higher risk of OA progression (area under the curve = 0.691, OR = 6.00) compared to those not overweight (area under the curve = 0.568, OR = 1.91).

Conclusion

Knee effusion may be an indicator of the progression of early-stage knee OA.

Peer Review reports

Background

Knee osteoarthritis (OA) is one of the most common causes of chronic pain, stiffness, and disability, and has enormous medical and socioeconomic burdens [1,2,3]. OA was ranked as the 11th highest contributor to global disability in the Global Burden of Disease 2010 project [4]. Early diagnosis of knee OA and early intervention are important to reduce this increasing burden [5,6,7,8].

The prevalence of abnormalities detected on magnetic resonance imaging (MRI) and of bone marrow lesions, meniscal lesions, and synovitis were higher in patients with early knee osteoarthritis (EKOA) than in those with normal knees [9]. Among these abnormalities, synovitis is reportedly a trigger of cartilage degeneration and is associated with the symptoms and grades of knee OA [10, 11]. Although some cross-sectional studies have revealed that mild synovitis or effusion exist in symptomatic knees without radiographic knee OA [12, 13], to our knowledge, no longitudinal studies have yet investigated the influence of effusion on the progression of knee OA in patients with EKOA.

Knee synovitis is sometimes characterized by a palpable joint swelling, which can arise from synovial hypertrophy and effusion in the joint cavity [11]. Imaging evaluation of effusion includes MRI, ultrasonography, and arthroscopy; ultrasonography is a valid and highly reliable method of assessment of synovitis [14,15,16]. Our previous study established a method for the quantitative measurement of the suprapatellar effusion area using ultrasonographic images in patients with radiographic knee OA [17]. Suprapatellar effusion was also reported to be an imaging biomarker for predicting the development of knee pain [18].

Methods

Aim

This study aimed to compare normal and EKOA knees to investigate the influence of effusion on the progression of knee OA in participants without radiographic knee OA. It was hypothesized that greater effusion would be observed in patients with EKOA and that it would correlate with the progression of knee OA.

Design

This was a retrospective follow-up study.

Setting

Data from the Iwaki Health Promotion Project was used. This project is a community-based preventive program that aims to improve the average life expectancy by conducting general health check-ups, as described previously [19,20,21,22]. Since 2005, it has been conducted annually in the general population living in the Iwaki region of Hirosaki City (western Aomori prefecture, Japan).

Participants

This study included participants who voluntarily participated in the Iwaki Health Promotion Project in 2016 and 2019. A total of 1,148 volunteers (459 men and 689 women) participated in the 2016 project. The participants answered questionnaires on their medical history, lifestyle, occupation, family history, health-related quality of life, and disease-specific information (such as knee symptoms). Here, we focused on participants without radiographic knee OA at baseline. We excluded 245, 282, 28, 4, and 3 participants whose radiographs revealed radiographic knee OA (Kellgren–Lawrence [KL] grade ≥ 2), whose ultrasonography data were incomplete, who did not undergo radiography, who had undergone knee arthroplasty, and who had a history of knee ligament injury or fracture, respectively. In total, 404 participants (182 men and 222 women) were followed up in the 2019 project and included in the analysis (follow-up rate: 68.9%). Participants with a body mass index (BMI) ≥ 25 kg/m2 were classified as overweight.

Radiographs

Knee radiographic examinations were performed using the CXDI-40EG Digital Radiography System. Experienced radiologic technicians and orthopedic surgeons obtained weight-bearing, full extension, and anterior–posterior radiographs of both knees with foot-map positioning upon check-up. The beam was positioned parallel to the floor at no angles and was aimed at the joint space. The sequencing was set at 60 kV, 50 mA, and 80 ms for all participants. Radiographic knee OA was diagnosed by a KL grade ≥ 2 in the more affected knee [23]. Only participants with no radiographic knee OA at baseline were included in the analysis. There were no participants with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis. At the 3-year follow-up, we defined knees with a KL grade of 0 or 1 as non-progressors and knees with radiographic knee OA as radiographic progressors. All joints were graded by two trained physicians (DC and ES) who had > 10 years of experience, and any discrepancies were resolved by mutual consultation.

Suprapatellar effusion area evaluated by ultrasonography

Knee effusion was assessed based on the suprapatellar effusion area detected by ultrasonography, as described previously [17]. To reduce bias, all assessments of ultrasonography were performed by a trained physician (DC) with 10 years of experience in musculoskeletal ultrasonographic evaluation. The participants were examined in the supine position, with both knees semi-flexed and feet in the neutral position. The semi-flexed knee position was defined by placing a pillow beneath both popliteal areas. Longitudinal ultrasound scans of the suprapatellar region were obtained; a linear transducer (12 MHz, ViamoTM) was gently placed over the same area at the center and proximal poles of the patella. On these images, an echo-free space in the suprapatellar region was traced. The suprapatellar effusion area (mm2) was automatically calculated. In the present study, we did not evaluate the hypertrophic synovial soft tissue (i.e., we only evaluated the echo-free space). All ultrasound images were traced by a trained physician (SO). To investigate the intra- and inter-observer reliabilities of this measurement, 50 randomly selected ultrasonography images were traced and calculated by another orthopedic surgeon (HI) at a different time point. The intra- and inter-observer reliabilities were 0.99 (95% confidence interval [CI]: 0.987–0.996) and 0.94 (95% CI: 0.875–0.976), respectively.

Classification criteria for early knee OA

EKOA was diagnosed according to the classification criteria proposed by the first international early knee OA workshop in Tokyo [8]. All participants answered the Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire independently. The KOOS self-administered questionnaire consists of 42 knee-related items and five subscales: pain, symptoms, activities of daily living, sports and recreation (sports), and knee-related quality of life [24,25,26]. All items were scored from 0 to 4, and the scores were then summed. Next, the raw scores were converted to a 0–100 scale, with 100 representing the best result and 0 representing the worst. The classification criteria for EKOA were as follows: (A) KOOS: two of the four subscales (with the exception of KOOS sports) were required to score “positive” (i.e., ≤ 85%); (B) clinical examination: a minimum of joint-line tenderness or crepitus of the knee needed to be present; and (C) radiographs: KL grades of 0 or 1 at the standing, fixed flexion, and weight-bearing positions. Participants were divided into the non-OA group (i.e., without EKOA) and the EKOA group.

Statistical analysis

Demographic data of the non-OA and EKOA groups are expressed as means ± standard deviations. Demographic data were compared between the two groups using the chi-squared test for categorical variables and the Wilcoxon rank-sum test for continuous variables, because some demographic parameters were not normally distributed according to the Shapiro–Wilk test. The effusion area was compared between the two groups using the Wilcoxon rank-sum test. Additionally, knees were divided into non-progressors and radiographic progressors and compared using an analysis of variance (ANOVA) and the Tukey’s post hoc test. To estimate the optimal cut-off effusion area for diagnosing EKOA and predicting the radiographic progressors, a receiver operating characteristic (ROC) analysis was performed. The effusion area values were used as a single variable in this analysis. A false-positive fraction was plotted against the true-positive fraction, and the cut-off value was defined by the Youden’s index (based on sensitivity and specificity), and the area under the curve (AUC) was calculated. Finally, multiple logistic regression analysis was conducted with the progression to knee OA at the 3-year follow-up as the dependent variable and with sex, BMI, prevalence of EKOA, and effusion area at baseline as the independent variables. Data input and analysis were performed using the JMP Pro software, version 13 (SAS Institute Inc., Cary, NC, USA). Statistical significance was set at p < 0.05.

Results

Fifty-five of the 404 participants (14%) were classified into the EKOA group at baseline, with an EKOA prevalence of 10% in men and 21% in women. The overall mean age was 50.7 ± 13.3 years and the mean BMI was 22.7 ± 3.1 kg/m2 at baseline. The mean effusion areas detected by ultrasonography in the non-OA and EKOA groups were 39.9 ± 34.2 mm2 and 54.6 ± 39.5 mm2 in men (p = 0.048) and 31.2 ± 30.8 mm2 and 50.9 ± 48.1 mm2 in women (p = 0.002), respectively (Table 1). The number of patients with overweight was 88 (men; 50 and women; 36). ROC analysis revealed that the optimal effusion area cut-off value for diagnosing EKOA was 29 mm2 (AUC = 0.587, OR: 2.92, p = 0.025) in women (Fig. 1). The sensitivity and specificity were 63% and 63%, respectively. We were unable to determine the optimal cut-off value for effusion area in men (n.s.).

Fig. 1
figure 1

Receiver operating characteristic curves for the effusion area and early knee osteoarthritis diagnosis. a ROC curve for male participants and b ROC curve for female participants. ROC: receiver operating characteristic, TPF: true-positive fraction, FPF: false-positive fraction, AUC: area under the curve

Full size image
Table 1 Clinical characteristics of the participants
Full size table

At the 3-year follow-up, there were 37 (22%), 7 (41%), 77 (42%), and 25 (66%) radiographic progressors in the male non-OA, male EKOA, female non-OA, and female EKOA subgroups, respectively (Table 2). The proportion of radiographic progressors was significantly higher in the EKOA group than in the non-OA group (32 [58%] vs. 114 [32%], p = 0.003). Next, we compared the effusion areas between the non-progressors and radiographic progressors in the non-OA and EKOA groups. Radiographic progressors tended to show a greater effusion area, but a significant difference was only noted between the radiographic progressors in the female EKOA subgroup and non-progressors in the female non-OA subgroup (p = 0.006; Fig. 2). Logistic regression analysis revealed that female sex (OR 3.36, 95% CI 2.98–5.42), EKOA (OR 2.02, 95% CI 1.08–3.75), body mass index (BMI; OR 1.11, 95% CI 1.02–1.19), and effusion area (OR 1.01, 95% CI 1.01–1.02) were significantly correlated with knee OA progression (Table 3). Based on the results of the logistic regression analysis, ROC analysis was performed to determine the optimal cut-off value of the effusion area for predicting radiographic progressors in female participants with and without a BMI ≥ 25 kg/m2 (overweight). The cut-off value of the effusion area was 31 mm2 (AUC = 0.691, OR: 6.00, p = 0.029) in overweight women. The sensitivity and specificity were 60% and 78%, respectively (Fig. 3).

Fig. 2
figure 2

Effusion area at the baseline in non-progressors and radiographic progressors. a Box plots for male participants and b Box plots for female participants. Box plots show the median (central line inside the box), upper and lower quartiles (bounds of box), and the largest and smallest values. p < 0.05 indicates significance (*) in the ANOVA and the Tukey’s method. ANOVA: analysis of variance

Full size image
Fig. 3
figure 3

Receiver operating characteristic curves for the effusion area and for predicting the progression of knee osteoarthritis in participants who were and were not overweight. a ROC curve for male participants and b ROC curve for female participants. ROC: receiver operating characteristic, TPF: true-positive fraction, FPF: false-positive fraction, AUC: area under curve

Full size image
Table 2 Knee osteoarthritis in participants with non-osteoarthritis and early knee osteoarthritis at the baseline and changes over 3 years
Full size table
Table 3 Examination of factors related to the progression to knee osteoarthritis
Full size table

Discussion

This study has several important findings regarding risk factors of progression in patients with EKOA. The suprapatellar effusion area was higher in the EKOA group than in the non-OA group. Further, logistic regression analysis and ROC analysis revealed that a higher effusion area and higher BMI may be risk factors for knee OA progression. These results suggest that effusion may be associated with the progression of knee OA in the early stage.

OA is sometimes referred to as a non-inflammatory disease because the leukocyte count in the synovial fluid is lower in OA than in rheumatoid arthritis [27]. However, synovial activation and hypervascularization are positively correlated with the KL grade [17, 28,29,30]. Clinically, synovitis directly causes several knee symptoms, such as knee swelling, pain, and heat. Inflamed synoviocytes release several catabolic and proinflammatory mediators that lead to an overproduction of proteolytic enzymes, thereby causing cartilage degeneration [31]. Animal studies have assessed several treatments for synovitis that are designed to interfere with specific biological molecules, such as anti-tumor necrosis factor agents, anti-nerve growth factor antibodies, and antiproteases (anti-matrix metalloproteinases and anti-ADMATS) [32,33,34]. Some have reported that suppressing inflamed synoviocytes offers a protective effect on cartilage degeneration [11]. Thus, synovitis and effusion are important targets and biomarkers for knee OA. However, the influence and pathophysiology of knee effusion in EKOA remain unclear.

Knee effusion was found to be negatively correlated with the knee symptoms in both the early and late stages of knee OA [12, 13, 35]. Our previous MRI-based study investigated the prevalence of abnormalities on MRI, such as cartilage damage, bone marrow lesions, subchondral cysts, bone attrition, osteophytes, meniscal lesions, and synovitis, in general Japanese women without radiographic knee OA. Among these abnormalities, synovitis was positively associated with the presence of EKOA (odds ratio = 2.254, p = 0.002) and was most strongly associated with knee pain. Furthermore, we quantitatively evaluated the effusion volume on MRI. The effusion volume was higher in patients with EKOA than in those with normal knees [12]. In the present study, we evaluated the suprapatellar effusion area using ultrasonography, which showed the ability to evaluate synovial disease with an efficacy similar to that obtained with MRI and arthroscopy [14, 15]. Similar to our previous study, this study showed that the effusion area detected by ultrasonography was higher in patients with EKOA than in those with normal knees (even in male patients).

The KL grade is widely used to define radiographic knee OA [36]. However, knees with radiographic knee OA (KL grade ≥ 2) already exhibit irreversible structural changes. Luyten et al. proposed the following new EKOA classification criterion to intervene in knee OA before these irreversible changes occur [8]: no structural changes noted during standard radiographical examination. Although radiography is an attractive assessment method that can be used in clinical settings using standard tools, the pathogenesis and natural history of EKOA remain largely unknown. Recently, Mahmoudian et al. reported classification criteria that could contribute moderately to improve the detection of knees at a high risk of OA progression (sensitivity: 33% and specificity: 74%) from a longitudinal cohort study [37]. Our study also showed that the proportion of knees whose KL grades progressed over a 3-year follow-up was significantly higher in the EKOA group than in the non-OA group.

Obesity is a well-known risk factor for knee OA, and weight loss is recommended to reduce the symptoms of knee OA [38, 39]. The association between obesity and knee pain is multifactorial, involving a simple increase in the mechanical load on the joints through daily activity, as well as an increase in the systemic and local inflammatory load caused by cytokine production from the adipose tissue [40, 41]. A recent study reported that obesity was significantly associated with a greater prevalence and severity of synovial inflammation, as detected by MRI [42]. Sasaki et al. found that risk factors of EKOA were female sex, aging, obesity, and knee injury history [43]. Thus, obesity and synovitis are modifiable risk factors for knee OA at an early stage. Our data showed the presence of knee effusion seemed to play a crucial role in knee OA progression, particularly in women with obesity. When investigating synovitis, previous studies reported that weight loss significantly reduced the size of infrapatellar fat pad synovitis [44, 45]. Of course, overweight and obesity status should be discussed in the context of its modification through personal, clinical, and public strategy [46]. Additionally, our univariate crude analysis showed that only higher BMI was not associated with knee OA progression. This may be due to the relatively low prevalence of overweight and obese participants in this study (mean BMI = 23.3). The role of weight loss in the progression of early-stage knee OA is still unclear, but it may be a potential target for preventing knee effusion from worsening and the progression of knee OA.

This study has several limitations. First, it was a single-center study; thus, selection bias cannot be ruled out. Therefore, multi-center studies are needed to validate our findings. Second, the study participants were determined via voluntary participation of the community residents. Because this check-up was performed as part of an annual general health check-up, we could not control for the follow-up rate. In addition, the number of participants with incomplete ultrasonography data was high. However, the differences between included and excluded participants showed no significant differences. Third, effusion was only examined in the suprapatellar region. It remains unclear whether other quantitative measurements, such as thickening of the synovial membrane and other sites with knee effusion, are associated with knee synovitis. Additionally, this was an observational study, so no conclusions can be drawn regarding cause-effect for effusion or thickening of synovial membrane and symptoms. Fourth, the number of participants with EKOA were limited, particularly male participants. We could not determine the optimal cut-off value of the effusion area for diagnosing EKOA in men. Thus, conclusions regarding differences between men and women could not be drawn. Fifth, we did not perform US analysis in our 2019 study. Evolution of effusion area and BMI may be more valuable factors in terms of progression of knee OA. However, we were unable to find the significant associations between delta values of BMI (difference of BMI between baseline and the 3-year follow-up) and progression of knee OA (p = 0.87). Sixth, we did not evaluate participants in the short term (i.e., 1 and 2 years). Typically, knee OA is a disorder that slowly progresses. Our previous study reported that mild effusion synovitis presented in participants with EKOA [12]. As we thought that mild synovitis slowly progresses to knee OA, we decided to evaluate the participants at 3 years and for as long as possible. We intend to perform a short-term follow-up in future studies. Finally, the differences between the symptoms of normal aging and EKOA remain unclear [47, 48]. In addition, participants with EKOA at baseline had higher BMI and age. These factors may affect the knee effusion area. The pathophysiology of effusion in patients with EKOA should be assessed carefully.

Despite these limitations, our study has several significant findings that have important clinical relevance for intervention in the early stages of knee OA. We showed a relationship between the baseline effusion area and the progression of knee OA in female participants without radiographic knee OA. Our findings suggest that knee effusion may be involved in the pathophysiology of EKOA and may be used as an indicator of progressive early-stage knee arthritis.

Conclusion

This study was the first to report on the influence of knee effusion on the progression of knee OA in patients with EKOA. Greater effusion area and an overweight status were identified as risk factors for the progression of knee OA, even in patients without radiographic knee OA. As this was an observational study, no conclusions can be drawn regarding causation between effusion and knee OA progression. However, effusion is one of the crucial pathologies in EKOA, and future studies should examine the cause of effusion in patients with EKOA.

Availability of data and materials

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AUC:

Area under the curve

ANOVA:

Analysis of variance

BMI:

Body mass index

CI:

Confidence interval

EKOA:

Early knee osteoarthritis

KOOS:

Knee injury and Osteoarthritis Outcome Score

KL:

Kellgren–Lawrence

MRI:

Magnetic resonance imaging

OA:

Osteoarthritis

OR:

Odds ratio

RKOA:

Radiographic knee osteoarthritis

ROC:

Receiver operating characteristic

References

  1. Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: a lancet commission. Lancet. 2020;396:1711–2.

    Article  PubMed  Google Scholar 

  2. Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, et al. Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab. 2009;27:620–8.

    Article  PubMed  Google Scholar 

  3. Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185–99.

    Article  PubMed  Google Scholar 

  4. Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of Disease 2010 study. Ann Rheum Dis. 2014;73:1323–30.

    Article  PubMed  Google Scholar 

  5. Madry H, Kon E, Condello V, Peretti GM, Steinwachs M, Seil R, et al. Early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2016;24:1753–62.

    Article  PubMed  Google Scholar 

  6. Emery CA, Whittaker JL, Mahmoudian A, Lohmander LS, Roos EM, Bennell KL, et al. Establishing outcome measures in early knee osteoarthritis. Nat Rev Rheumatol. 2019;15:438–48.

    Article  PubMed  Google Scholar 

  7. Luyten FP, Dent M, Filardo G, Kon E, Engebretsen L. Definition and classification of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2012;20:401–6.

    Article  PubMed  Google Scholar 

  8. Luyten FP, Bierma-Zeinstra S, Dell’Accio F, Kraus VB, Nakata K, Sekiya I, et al. Toward classification criteria for early osteoarthritis of the knee. Semin Arthritis Rheum. 2018;47:457–63.

    Article  CAS  PubMed  Google Scholar 

  9. Ota S, Sasaki E, Sasaki S, Chiba D, Kimura Y, Yamamoto Y, et al. Relationship between abnormalities detected by magnetic resonance imaging and knee symptoms in early knee osteoarthritis. Sci Rep. 2021;11:15179.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Shimura Y, Kurosawa H, Sugawara Y, Tsuchiya M, Sawa M, Kaneko H, et al. The factors associated with pain severity in patients with knee osteoarthritis vary according to the radiographic disease severity: a cross-sectional study. Osteoarthritis Cartilage. 2013;21:1179–84.

    Article  CAS  PubMed  Google Scholar 

  11. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625–35.

    Article  CAS  PubMed  Google Scholar 

  12. Ishibashi K, Sasaki E, Ota S, Chiba D, Yamamoto Y, Tsuda E, et al. Detection of synovitis in early knee osteoarthritis by MRI and serum biomarkers in japanese general population. Sci Rep. 2020;10:12310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Perry TA, Parkes MJ, Hodgson RJ, Felson DT, Arden NK, O’Neill TW. Association between bone marrow lesions & synovitis and symptoms in symptomatic knee osteoarthritis. Osteoarthritis Cartilage. 2020;28:316–23.

    Article  CAS  PubMed  Google Scholar 

  14. Walther M, Harms H, Krenn V, Radke S, Faehndrich TP, Gohlke F. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 2001;44:331–8.

    Article  CAS  PubMed  Google Scholar 

  15. Fiocco U, Cozzi L, Rubaltelli L, Rigon C, De Candia A, Tregnaghi A, et al. Long-term sonographic follow-up of rheumatoid and psoriatic proliferative knee joint synovitis. Br J Rheumatol. 1996;35:155–63.

    Article  CAS  PubMed  Google Scholar 

  16. Meenagh G, Filippucci E, Iagnocco A, Delle Sedie A, Riente L, Bombardieri S, et al. Ultrasound imaging for the rheumatologist VIII. Ultrasound imaging in osteoarthritis. Clin Exp Rheumatol. 2007;25:172–5.

    CAS  PubMed  Google Scholar 

  17. Chiba D, Tsuda E, Maeda S, Sasaki E, Takahashi I, Nakaji S, et al. Evaluation of a quantitative measurement of suprapatellar effusion by ultrasonography and its association with symptoms of radiographic knee osteoarthritis: a cross-sectional observational study. Arthritis Res Ther. 2016;18:181.

    Article  PubMed  PubMed Central  Google Scholar 

  18. D’Agostino MAD, Conaghan P, Le Bars M, Baron G, Grassi W, Martin-Mola E, et al. EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis. Ann Rheum Dis. 2005;64:1703–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ota S, Chiba D, Sasaki E, Kumagai G, Yamamoto Y, Nakaji S, et al. Symptomatic bone marrow lesions induced by reduced bone mineral density in middle-aged women: a cross-sectional japanese population study. Arthritis Res Ther. 2019;21:113.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sasaki E, Sasaki S, Chiba D, Yamamoto Y, Nawata A, Tsuda E, et al. Age-related reduction of trunk muscle torque and prevalence of trunk sarcopenia in community-dwelling elderly: validity of a portable trunk muscle torque measurement instrument and its application to a large sample cohort study. PLoS ONE. 2018;13:e0192687.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sasaki E, Tsuda E, Yamamoto Y, Maeda S, Inoue R, Chiba D, et al. Serum hyaluronic acid concentration predicts the progression of joint space narrowing in normal knees and established knee osteoarthritis - a five-year prospective cohort study. Arthritis Res Ther. 2015;17:283.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Chiba D, Sasaki E, Ota S, Maeda S, Sugiyama D, Nakaji S, et al. US detection of medial meniscus extrusion can predict the risk of developing radiographic knee osteoarthritis: a 5-year cohort study. Eur Radiol. 2020;30:3996–4004.

    Article  PubMed  Google Scholar 

  23. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome score (KOOS) - development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28:88–96.

    Article  CAS  PubMed  Google Scholar 

  24. Nakamura N, Takeuchi R, Sawaguchi T, Ishikawa H, Saito T, Goldhahn S. Cross-cultural adaptation and validation of the japanese knee Injury and Osteoarthritis Outcome score (KOOS). J Orthop Sci. 2011;16:516–23.

    Article  PubMed  Google Scholar 

  25. Bekkers JEJ, de Windt TS, Raijmakers NH, Dhert WJA, Saris DBF. Validation of the knee Injury and Osteoarthritis Outcome score (KOOS) for the treatment of focal cartilage lesions. Osteoarthritis Cartilage. 2009;17:1434–9.

    Article  CAS  PubMed  Google Scholar 

  26. Kellgren JH, Lawrence RC. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Dougados M. Synovial fluid cell analysis. Baillieres Clin Rheumatol. 1996;10:519–34.

    Article  CAS  PubMed  Google Scholar 

  28. Loeuille D, Rat AC, Goebel JC, Champigneulle J, Blum A, Netter P, et al. Magnetic resonance imaging in osteoarthritis: which method best reflects synovial membrane inflammation? Correlations with clinical, macroscopic and microscopic features. Osteoarthritis Cartilage. 2009;17:1186–92.

    Article  CAS  PubMed  Google Scholar 

  29. Roemer FW, Kassim Javaid M, Guermazi A, Kiran A, Keen R, et al. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI. Osteoarthritis Cartilage. 2010;18:1269–74.

    Article  CAS  PubMed  Google Scholar 

  30. Lindblad S, Hedfors E. Intraarticular variation in synovitis. Local macroscopic and microscopic signs of inflammatory activity are significantly correlated. Arthritis Rheum. 1985;28:977–86.

    Article  CAS  PubMed  Google Scholar 

  31. Schue JR, Tawfik O, Smith DD, Hinson G, Bolce R, Wick JA, et al. Treatment of knee osteoarthritis with intraarticular infliximab may improve knee function and reduce synovial infiltration by macrophages. Arthritis Rheum. 2011;63:10.

    Google Scholar 

  32. Berenbaum F. Targeted therapies in osteoarthritis: a systematic review of the trials on www.clinicaltrials.gov. Best Pract Res Clin Rheumatol. 2010;24:107–19.

    Article  PubMed  Google Scholar 

  33. Abdiche YN, Malashock DS, Pons J. Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors. Protein Sci. 2008;17:1326–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Malemud CJ. Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging. 2010;27:95–115.

    Article  CAS  PubMed  Google Scholar 

  35. Wang X, Jin X, Han W, Cao Y, Halliday A, Blizzard L-, et al. Cross-sectional and longitudinal associations between knee joint effusion synovitis and knee pain in older adults. J Rheumatol. 2016;43:121–30.

    Article  PubMed  Google Scholar 

  36. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Mahmoudian A, Lohmander LS, Jafari H, Luyten FP. Towards classification criteria for early-stage knee osteoarthritis: a population-based study to enrich for progressors. Semin Arthritis Rheum. 2021;51:285–91.

    Article  PubMed  Google Scholar 

  38. Cuzdan Coskun N, Ay S, Evcik FD, Oztuna D. Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients? Int J Rheum Dis. 2017;20:1942–9.

    Article  CAS  PubMed  Google Scholar 

  39. Gabay O, Hall DJ, Berenbaum F, Henrotin Y, Sanchez C. Osteoarthritis and obesity: experimental models. Jt Bone Spine. 2008;75:675–9.

    Article  Google Scholar 

  40. Sowers MR, Karvonen-Gutierrez CA. The evolving role of obesity in knee osteoarthritis. Curr Opin Rheumatol. 2010;22:533–7.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Tan W, Wang F, Zhang M, Guo D, Zhang Q, He S. High adiponectin and adiponectin receptor 1 expression in synovial fluids and synovial tissues of patients with rheumatoid arthritis. Semin Arthritis Rheum. 2009;38:420–7.

    Article  CAS  PubMed  Google Scholar 

  42. Kanthawang T, Bodden J, Joseph GB, Lane NE, Nevitt M, McCulloch CE, et al. Obese and overweight individuals have greater knee synovial inflammation and associated structural and cartilage compositional degeneration: data from the osteoarthritis initiative. Skeletal Radiol. 2021;50:217–29.

    Article  PubMed  Google Scholar 

  43. Sasaki E, Ota S, Chiba D, Kimura Y, Sasaki S, Yamamoto Y, et al. Early knee osteoarthritis prevalence is highest among middle-aged adult females with obesity based on new set of diagnostic criteria from a large sample cohort study in the japanese general population. Knee Surg Sports Traumatol Arthrosc. 2020;28:984–94.

    Article  PubMed  Google Scholar 

  44. Pogacnik AL, Eckstein F, Wirth W, Beavers D, Loeser RF, Nicklas BJ, et al. Impact of diet and/or exercise intervention on infrapatellar fat pad morphology: secondary analysis from the intensive diet and exercise for arthritis (IDEA) trial. Cells Tissues Organs. 2017;203:258–66.

    Article  Google Scholar 

  45. Eva SD, Torben D, Wolfgang W, Felix E. Responsiveness of infrapatellar fat pad volume change to body weight loss or gain: data from the osteoarthritis initiative. Cells Tissues Organs. 2018;205:53e62.

    Google Scholar 

  46. Georgiev T, Angelov AK. Modifiable risk factors in knee osteoarthritis: treatment implications. Rheumatol Int. 2019;39:1145–57.

    Article  PubMed  Google Scholar 

  47. Magnusson K, Kumm J, Turkiewicz A, Englund M. A naturally aging knee, or development of early knee osteoarthritis? Osteoarthritis Cartilage. 2018;26:1447–52.

    Article  CAS  PubMed  Google Scholar 

  48. Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12:412–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank all staff members for helping us conduct the Iwaki Health Promotion Project. This paper is based on work that was presented previously at the 2022 OARSI World Congress on Osteoarthritis, 7–10 April 2022 in Berlin and was published as a conference abstract. This abstract may be accessed at: https://www.sciencedirect.com/science/article/abs/pii/S1063458422000541?via%3Dihub.

Funding

This study was supported in part by JST COI (Grant Number JPMJCE1302), Grants-in-Aid from the Japanese Society for the Promotion of Science (Nos. 21500676, 18K16606, and 18K09091), Health Labor Sciences Research Grant, JOA-Subsidized Science Project Research from the Japanese Orthopedic Association, and a grant from the Japan Orthopedics and Traumatology Research Foundation (No. 421).

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, 036-8562, Hirosaki, Aomori, Japan

    Kyota Ishibashi, Eiji Sasaki, Daisuke Chiba, Tetsushi Oyama, Seiya Ota, Hikaru Ishibashi, Yuji Yamamoto & Yasuyuki Ishibashi

  2. Department of Rehabilitation Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan

    Eiichi Tsuda

  3. Department of Social Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan

    Kaori Sawada

  4. Department of Digital Nutrition and Health Sciences, Graduate School of Medicine, Hirosaki University, Hirosaki, Aomori, Japan

    Songee Jung

Authors
  1. Kyota Ishibashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eiji Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daisuke Chiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tetsushi Oyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seiya Ota
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hikaru Ishibashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuji Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eiichi Tsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kaori Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Songee Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yasuyuki Ishibashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.I.: Conception and design, data analysis and interpretation, first manuscript writing; E.S.: Conception and design, data interpretation, manuscript writing; D.C.: Conception and design, data interpretation; S.J.: Advised statical analysis and data interpretation; T.O., H.I., S.O., and K.S.: Data collection and assembly; E.T., Y.Y., and Y.I.: Conception and design. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Kyota Ishibashi.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the ethics committee of the Hirosaki University Graduate School of Medicine (reference numbers: 2016-028 and 2019-009) and was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All participants provided written informed consent prior to participation.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ishibashi, K., Sasaki, E., Chiba, D. et al. Effusion detected by ultrasonography and overweight may predict the risk of knee osteoarthritis in females with early knee osteoarthritis: a retrospective analysis of Iwaki cohort data. BMC Musculoskelet Disord 23, 1021 (2022). https://doi.org/10.1186/s12891-022-05989-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12891-022-05989-0

Keywords